|
Apotex Launches Haloperidol Pre-Filled Syringe
The Company Is First to Offer Haloperidol Injection in PFS
Weston,
FL (January 28, 2005) — Apotex Corp. today announced that it has commenced shipment
of Haloperidol 5mg/mL pre-filled syringes. Apotex’ haloperidol injection is AP rated to Ortho Mc Neil’s Haldol® injection.
Apotex’ haloperidol is available in a 1mL single-dose, pre-filled syringe, with a sealed tip for added security.
The pre-filled syringes are packaged in cartons of ten. Each individual syringe is bar-coded with an NDC lot number
and expiration date for ease in effective tracking and quality control.
“Apotex is pleased to be the first company to supply haloperidol in a pre-filled syringe, providing a more convenient
and easier-to-use injectable delivery system” said Apotex Corp. President Tammy McIntire. “Our FDA-approved haloperidol
pre-filled syringe is competitively priced to other haloperidol single dose vial products currently offered in the
market,” McIntire added.
Annual sales for the haloperidol single dose vial are approximately $9.6 million.
The Apotex Group manufactures more than 50 different high-quality generic pharmaceuticals, used by millions of patients
worldwide. Its FDA-approved product line includes oral solids and liquids, injectables, nasal sprays, ophthalmics and
inhalation solutions.
Haldol® is a registered trademark of Ortho Mc-Neil.
About Apotex Corp.
Apotex Corp. is the U.S. subsidiary of Apotex Inc., the largest manufacturer of generic prescription medicines in Canada. Apotex products are sold in 115 countries around the world and include oral solids, liquids, injectables, nasal sprays, ophthalmics and inhalation solutions. Through its sales and marketing headquarters in Weston, Florida, operations center in Indianapolis, and research facility in Lincolnshire, Illinois, Apotex Corp. is committed to providing quality, safe and affordable generic medicines to the U.S. market. For more information visit
apotexcorp.com.
# # #
|
